Zhang, H., Wang, Q., Liu, J., & Cao, H. (2018). Inhibition of the PI3K/Akt signaling pathway reverses sorafenib-derived chemo-resistance in hepatocellular carcinoma. Oncol Lett.
Citação norma ChicagoZhang, Hao, Qingqing Wang, Jun Liu, and Haoqiang Cao. "Inhibition of the PI3K/Akt Signaling Pathway Reverses Sorafenib-derived Chemo-resistance in Hepatocellular Carcinoma." Oncol Lett 2018.
Citação norma MLAZhang, Hao, Qingqing Wang, Jun Liu, and Haoqiang Cao. "Inhibition of the PI3K/Akt Signaling Pathway Reverses Sorafenib-derived Chemo-resistance in Hepatocellular Carcinoma." Oncol Lett 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.